[Iatrogenic Cushing syndrome in an HIV-infected female patient: be careful about interaction inhaled corticosteroids-ritonavir!].
Bouldouyre
Marie-Anne
MA
Pôle de médecine interne, Hôpital Cochin, F-75014 Paris, France. ma.bouldouyre@gmail.com
Moachon
Laurence
L
Guillevin
Loïc
L
Launay
Odile
O
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000009:adverse effects*; D003480:Cushing Syndrome / Q000139:chemically induced*; D004338:Drug Combinations; D004347:Drug Interactions; D005260:Female; D000068297:Fluticasone-Salmeterol Drug Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D007049:Iatrogenic Disease; D019438:Ritonavir / Q000009:adverse effects*
D000305:Adrenal Cortex Hormones; D000730:Androstadienes; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D017320:HIV Protease Inhibitors; D019438:Ritonavir; D000420:Albuterol